Cabozantinib impurity 1DYH
|
|
- CAS-Nr.
- 1621681-63-7
- Englisch Name:
- Cabozantinib impurity 1DYH
- Synonyma:
- Cabozantinib Impurity 04;Cabozantinib impurity 1DYH;N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-6,7-dimethoxyquinolin-4-amine;4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide ;N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
- CBNumber:
- CB15581295
- Summenformel:
- C28H24FN3O6
- Molgewicht:
- 517.51
- MOL-Datei:
- 1621681-63-7.mol
|
Cabozantinib impurity 1DYH Eigenschaften
- Dichte
- 1.36±0.1 g/cm3(Predicted)
- pka
- 13.86±0.70(Predicted)
Sicherheit
Cabozantinib impurity 1DYH Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Cabozantinib N-oxide is a impurity of Cabozantinib (X745500), a medication used to treat medullary thyroid cancer. As well, it can be used in biological study. Computational network biological approach based on pathway cross-talk inhibition identified new synergistic drug combinations using raloxifene and cabozantinib for treatment of human breast cancer in xenograft mouse model. Potent c-MET inhibitor.
Cabozantinib impurity 1DYH Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Cabozantinib impurity 1DYH Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 28)Lieferanten
1621681-63-7()Verwandte Suche:
- N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- Cabozantinib impurity 1DYH
- 1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
- 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide
- N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-6,7-dimethoxyquinolin-4-amine
- Cabozantinib Impurity 04
- 1621681-63-7
- C28H24FN3O6